Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study

AD Roth; AS Allal; Marie-Anne Brundler; R de Peyer; B Mermillod; I More; P Huber

doi:10.1093/annonc/mdg023

Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study

AD Roth, AS Allal, Marie-Anne Brundler, R de Peyer, B Mermillod, I More, P Huber

Research output: Contribution to journal › Article

43 Citations (Scopus)

Abstract

BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status

Original language	English
Pages (from-to)	110-115
Number of pages	6
Journal	Annals of Oncology
Volume	14
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdg023
Publication status	Published - 1 Jan 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdg023

Cite this

@article{106cab7b0e3c423f905bc4bc05d97400,

title = "Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study",

abstract = "BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status ",

author = "AD Roth and AS Allal and Marie-Anne Brundler and {de Peyer}, R and B Mermillod and I More and P Huber",

year = "2003",

month = jan,

day = "1",

doi = "10.1093/annonc/mdg023",

language = "English",

volume = "14",

pages = "110--115",

journal = "Annals of Oncology",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study

AU - Roth, AD

AU - Allal, AS

AU - Brundler, Marie-Anne

AU - de Peyer, R

AU - Mermillod, B

AU - More, I

AU - Huber, P

PY - 2003/1/1

Y1 - 2003/1/1

N2 - BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status

AB - BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status

UR - http://www.scopus.com/inward/record.url?scp=0037246633&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg023

DO - 10.1093/annonc/mdg023

M3 - Article

C2 - 12488302

VL - 14

SP - 110

EP - 115

JO - Annals of Oncology

JF - Annals of Oncology

IS - 1

ER -

Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this